Drug repurposing of ERK inhibitors to target the transcription factor Nfix in dystrophic muscles: development of a new proof-of-concept study to hinder Muscular Dystrophies (2° anno)

Project

Overview

Contributors

MESSINA GRAZIELLA   Scientific Manager  

Departments involved

Dipartimento di Bioscienze   Principale  

Type

INTLI - Finanziamenti internazionali

Funder

AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES
External Organization Funding Organization

Date/time interval

January 10, 2022 - January 9, 2025

Project duration

36 months

Research Areas

Concepts


Settore BIO/17 - Istologia